Nav: Home

Characterizing the Zika virus genome

August 05, 2016

The sudden emergence of the Zika virus epidemic in Latin America in 2015-16 has caught the scientific world unawares. A little known disease that was first diagnosed in the Zika forest environment of Uganda in 1947, the disease largely affected populations in Africa until its emergence in French Polynesia a few years ago and then in Brazil and South America last year. The Zika virus is spread mainly by the Aedes aegypti mosquitoes and, like the dengue virus, belongs to the flaviviridae family along with Japanese encephalitis and West Nile virus. As of now there are no known cures or prophylactics for Zika virus infections that cause chills, aches and fevers, but what makes it worse is the association of microcephaly (small brain case) in newborns and other neurological diseases such as the Guillian-Barre syndrome. The Olympic event in Rio this year is another cause for concern on the possibilities of increased spread of the disease around the world.

While governments in Latin America and elsewhere are concentrating on vector control and increasing citizen awareness, research labs around the world are deeply engaged in developing drugs and vaccines against the Zika virus. In this process understanding the character of the Zika virus in terms of its molecular biology is of vital concern, for the effectiveness of drugs and vaccines will largely depend on what we can fundamentally understand of the virus. The availability of nucleotide and protein sequence data has enabled this study using computer-based approaches to characterize the virus in terms of various biological properties of interest like phylogenetic relationships, transition-transversion ratios, amino acid usage, codon usage bias and hydropathy index.

Our studies showed that the Zika virus has close parallels to the dengue virus in several aspects such as transition-transversion ratios, preferential vector for its spread, genome structure and the like, with the genome structure being more convoluted with a large amount of complex base distribution along the sequence; these have been clearly evident in some of the 2D graphical representation plots. We have also reported very noticeable differences between the viral sequences isolated in African countries and the isolates from more recent periods in Asia, the Pacific regions and the Americas. The codon usage and amino acid counts also show remarkable differences in frequencies of some residues. These aspects of the Zika virus genome suggest qualitative changes have taken place between the older African sequences and the more recent variants circulating in the Asia-Pacific-America region. Since the outbreak in Yap island in 2007 and the recent epidemic in Brazil in 2015 have led to serious infections in pregnant women and reported cases of novel transmission through sexual contact, it is possible that some of the changes determined through this research could constitute factors facilitating this pathogenicity. Given the propensity of humans to travel and the consequences of climate change which are likely to aid the spread of the disease, these bioinformatics studies could form the basis of effective surveillance and closer monitoring of the genomes of the Zika virus. Some of the present authors have suggested computer-assisted approaches towards such surveillance and consequent design of drugs and vaccines to combat the growth and spread of Zika and other zoonotic viruses, which may be taken under advisement for the benefit of the populations at large.
Reference: Nandy, A.; et al. (2016). Characterizing the Zika Virus Genome - A Bioinformatics Study, Curr. Comput. Aided Drug Des., DOI: 10.2174/1573409912666160401115812

Bentham Science Publishers

Related Vaccines Articles:

Misinformation on vaccines readily available online
Parents researching childhood vaccinations online are likely to encounter significant levels of negative information, researchers at the University of Otago, Wellington, have found.
Battle with the cancer: New avenues from childhood vaccines
A new research from the University of Helsinki showed for the first time how the pre-immunization acquired through common childhood vaccines can be used to enhance therapeutic cancer treatment.
Personalized cancer vaccines
The only therapeutic cancer vaccine available on the market has so far showed very limited efficacy in clinical trials.
Doubts raised about effectiveness of HPV vaccines
A new analysis of the clinical trials of HPV vaccines to prevent cervical cancer raises doubts about the vaccines' effectiveness.
Egg-based flu vaccines: Not all they're cracked up to be?
Flu season is underway in the Northern Hemisphere, sickening millions of people and in rare cases, causing hospitalization or death.
You're probably not allergic to vaccines
Five facts about allergies to vaccines, pulled together by two McMaster University physicians.
Micromotors deliver oral vaccines
Vaccines have saved millions of lives, but nobody likes getting a shot.
Vaccines not protecting farmed fish from disease
The vaccines used by commercial fish farmers are not protecting fish from disease, according to a new study.
Bioengineers imagine the future of vaccines and immunotherapy
In the not-too-distant future, nanoparticles delivered to a cancer patient's immune cells might teach the cells to destroy tumors.
Pneumonia: Treatment with vaccines instead of antibiotics
A properly functioning immune system is key to resolve bacterial pneumonia.
More Vaccines News and Vaccines Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Climate Mindset
In the past few months, human beings have come together to fight a global threat. This hour, TED speakers explore how our response can be the catalyst to fight another global crisis: climate change. Guests include political strategist Tom Rivett-Carnac, diplomat Christiana Figueres, climate justice activist Xiye Bastida, and writer, illustrator, and artist Oliver Jeffers.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at